Inogen, Inc. INGN is well poised for growth in the coming quarters, backed by its high prospects in the portable oxygen concentrators (POCs) space. Solid performance in the second quarter of 2021 and ...
Needham analyst Michael Matson maintained a Hold rating on Inogen (INGN – Research Report) today. The company’s shares closed yesterday at $9.46. Matson covers the Healthcare sector, focusing on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback